Chronic Kidney Disease (CKD) Clinical Trial
— PREPAREDOfficial title:
Information and Financial Interventions for Kidney Donation in African Americans
Verified date | August 2018 |
Source | Johns Hopkins University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
African Americans are less likely than Whites to receive kidney transplants, despite their
being more than two-fold as likely as Whites to develop end stage renal disease (ESRD).
Living related kidney donation (LD) offers patients an opportunity to bypass many barriers to
receipt of deceased kidney transplants (e.g. waiting lists and immunological
incompatibility), but minorities are less likely to receive living related kidney transplants
(LRT). Evidence suggests African Americans may not discuss LD/LRT with their families or
physicians at optimal rates, and thus may not have adequate information to initiate or
participate in shared decision-making regarding LD/LRT. African Americans may also have
financial concerns regarding convalescence and out of pocket expenses related to LD/LRT,
another barrier impeding LD/LRT.
The primary goals of this study are to overcome these important barriers by enhancing ethnic
minorities' consideration of LD/LRT through the promotion of shared decision-making regarding
LD/LRT and provision of financial assistance for out of pocket expenses. The investigators
specific aims are: a) to develop culturally sensitive informational (audiovisual) and
financial interventions and b) to perform a randomized controlled trial to assess their
effectiveness in increasing pursuit of LD/LRT among African American patients with ESRD and
their families. The investigators hypothesize: (1) Patients and families who view
informational materials designed to promote shared decision-making regarding LD/LRT will be
more likely than patients and families not viewing these materials to discuss LD/LRT with
family and with health care professionals. Patients and families viewing such informational
materials will also be more likely than those not viewing these materials to pursue and
complete the LD/LRT process and (2) patients and their families who are offered the
intervention to promote shared decision-making plus a financial assistance intervention for
potential live kidney donors will be more likely than patients and families not offered both
interventions to pursue and complete the LD/LRT process.
Status | Completed |
Enrollment | 92 |
Est. completion date | April 2014 |
Est. primary completion date | April 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age 18 or older - End-stage renal disease (ESRD) receiving hemodialysis for less than 2 years - Self-reported as African-American - English Speaking Exclusion Criteria: - Dementia - Prior Kidney Transplant - Non-English Speaking - Cancer within 2 years prior to recruitment date - Stage 4 Congestive Heart Failure - End Stage Liver Disease - Unstable Coronary Artery Disease - Pulmonary Hypertension - Severe Peripheral Vascular Disease - Chronic Debilitating Infections |
Country | Name | City | State |
---|---|---|---|
United States | Johns Hopkins University | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
Johns Hopkins University | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pursuit of Living Related Transplantation | Measurement of patients' pursuit of LRT will be performed using a series of questions that assess the participants' knowledge, interest, and perceived barriers to LRT. We will also ascertain use of the living donor financial assistance among potential donors and completion of evaluation and kidney transplant among both patient participants and potential living donors. | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05422755 -
The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients
|
||
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Recruiting |
NCT04064827 -
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02218099 -
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
|
Phase 1/Phase 2 | |
Completed |
NCT02276742 -
Lifestyle Management of CKD in Obese Diabetic Patients
|
N/A | |
Completed |
NCT01222234 -
Impact of Vitamin D Therapies on Chronic Kidney Disease
|
N/A | |
Recruiting |
NCT05106387 -
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive A Kidney Transplant
|
||
Completed |
NCT05373303 -
The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®
|
N/A | |
Completed |
NCT01247311 -
Vitamin D and the Health of Blood Vessels in Kidney Disease
|
N/A | |
Completed |
NCT04042350 -
Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on Dialysis
|
||
Completed |
NCT02733328 -
Assessment of Plasma and NGAL for the Early Prediction of Acute Kidney Injury After Cardiac Surgery in Adults Study
|
||
Completed |
NCT02341664 -
Patient and Provider Assessment of Lipid Management Registry
|
||
Enrolling by invitation |
NCT06322641 -
A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
|
||
Completed |
NCT05755373 -
A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists
|
||
Completed |
NCT02678000 -
Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
|
Phase 2 | |
Completed |
NCT02185911 -
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
|
N/A | |
Terminated |
NCT03226899 -
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment
|
Phase 4 | |
Completed |
NCT02504294 -
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
|
Phase 3 | |
Active, not recruiting |
NCT04094831 -
Community-based Screening of Chronic Kidney Disease (CKD) and Measure the Impact of Health Education
|
N/A | |
Completed |
NCT01810939 -
A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)
|
Phase 3 |